Cetuximab is an epidermal growth factor receptor (egfr) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion.
Voir plus de détails